The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee
- 1 February 1996
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 18 (1) , 114-124
- https://doi.org/10.1016/s0149-2918(96)80184-6